Transcription of United Nations Conference on Trade and …
{{id}} {{{paragraph}}}
Example: dental hygienist
United Nations Conference on Trade and …
United Nations Conference on Trade and development Ad Hoc Expert Group Meeting New Investment Models in Health-related R&D the Case of Antibiotic Resistance Thursday, 5 October 2017 Room XXVII, Palais des Nations Geneva, Switzerland Report 1. Executive Summary In response to its mandate to work on the development implications of intellectual property within the broader context of investment, UNCTAD s Intellectual Property (IP) Unit organized an ad hoc expert group meeting on the topic of New Investment Models in Health-related R&D the Case of Antibiotic Resistance on 5 October 2017 at the Palais des Nations in Geneva. The key outcome of the discussion was that more public and private investment is required to promote research and development (R&D) in the creation of new classes of antibiotic drugs. While a variety of proposals exist on how to delink the costs of R&D from the sales volume and drugs prices, governments have for the time being not committed sufficient amounts of funding to ensure a systemic shift of the R&D system from the volume-oriented business model to effective market entry rewards (MERs).
United Nations Conference on Trade and Development Ad Hoc Expert Group Meeting New Investment Models in Health-related R&D – the Case of Antibiotic Resistance Thursday, 5 October 2017
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: